the changing standard of care in dlbcl
Published 4 months ago • 85 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
7:16
changes in the classification of dlbcl
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
3:04
applying molecular understanding of dlbcl to management strategies
-
12:05
how to clean/change biobase hematology valves
-
21:38
drawing the line: the rationale behind blood tube collection order
-
3:28
world class care beyond borders | gleneagles hospital johor
-
2:16
alexander: bicistronic cd19 & cd22 car for dlbcl
-
2:53
autohct in dlbcl in the car-t era
-
2:46
transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
-
0:42
targeted therapies for dlbcl treatment
-
1:10
next-generation btk inhibitors and their role in the cll treatment landscape
-
1:15
personalized medicine for dlbcl
-
1:06
how can we monitor a patient’s quality of life?
-
0:41
isct in bringing together the scientific community
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:09
heart transplantation in attr amyloidosis
-
2:19
italian perspective: managing dlbcl
-
3:10
novel aml treament approaches